Abstract
Pericardial effusion was noted in 43 of 79 patients (54%) with severe primary pulmonary hypertension. Larger effusion was associated with hemodynamic and echocardiographic evidence of right heart failure, impaired exercise tolerance, and a poor 1-year prognosis.
Publication types
-
Clinical Trial
-
Comparative Study
-
Multicenter Study
-
Randomized Controlled Trial
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adult
-
Antihypertensive Agents / administration & dosage
-
Antihypertensive Agents / therapeutic use
-
Echocardiography, Doppler
-
Epoprostenol / administration & dosage
-
Epoprostenol / therapeutic use
-
Female
-
Follow-Up Studies
-
Humans
-
Hypertension, Pulmonary / complications*
-
Hypertension, Pulmonary / diagnosis
-
Hypertension, Pulmonary / drug therapy
-
Infusions, Intravenous
-
Male
-
Pericardial Effusion / diagnosis
-
Pericardial Effusion / epidemiology*
-
Pericardial Effusion / etiology
-
Prevalence
-
Prognosis
-
Pulmonary Wedge Pressure
-
Survival Rate
Substances
-
Antihypertensive Agents
-
Epoprostenol